ONESOURCE.NS
ONESOURCE.NS
INE013P01021
ONESOURCE SPECL PHARMA L
Loading chart...

Financials

Trends
* Timeframes marked with (Est.) are analyst estimates based on consensus data.
Details
Breakdown 2026 2025 Change %
Total Revenue 14.215.900.000 14.448.530.000
1.6%
Cost of Revenue 4.446.490.000 4.350.340.000
2.2%
Gross Profit 9.769.410.000 10.098.190.000
3.3%
9.824.080.000 8.193.820.000
19.9%
Operating Income -54.670.000 1.904.370.000
102.9%
Pretax Income -919.610.000 -670.660.000
37.1%
Net Income Common Stockholders -738.030.000 -179.710.000
310.7%
-- --
--
-- --
--
ende